Group items tagged

The European biosimilars market continues to evolve across all key areas, from clinical to commercial and beyond.Despite improvements in awareness, information gaps on biosimilars still exist.The biosimilar pipeline continues to advance, with positive clinical data being published for several key pipeline programmes

Nicotine Addiction pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

The low manufacturing costs in the country enable Indian companies to manufacture generic drugs at costs lower than the cost at which companies operating in regulated markets manufacture. Consequently, this has created a huge export opportunity for Indian companies.

Nanomedicine is an offshoot of nanotechnology, and refers to highly-specific medical intervention at the molecular scale for curing diseases or repairing damaged tissues.

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. During the next ten years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself.

Diabetes Disposable Insulin Pen Market is anticipated to surpass US$ 4 Billion across the top 5 European countriesof the France, Germany, Italy, Spain and United Kingdom by 2022.

Biopharmaceuticals represent one of the most elegant and sophisticated achievements of modern science. Compared to small molecules which are synthesized chemically, biopharmaceuticals or biologics are manufactured from biological sources and have proved to be efficacious in the treatment of various chronic and other rare diseases for which there are no available treatments.